NCT Number: NCT00228046
Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder
This study will assess whether adding a mood stabilizer, divalproex sodium, to stimulant treatment is more effective than stimulant treatment alone in reducing aggressive behavior among children with attention deficit hyperactivity disorder (ADHD).
Looking for future studies?
Notify MeKey information
Conditions
Age range
6 year–14 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Long Island Jewish Medical Center / Schneider Children's Hospital, New Hyde Park, New York, United States
About this study
ADHD is one of the most common childhood mental disorders. It often causes impaired functioning in multiple areas, including home, school, and peer relationships. Additionally, children with ADHD often develop aggressive behavior, which is not usually adequately suppressed by standard stimulant treatments for ADHD. In order to address this problem, many physicians prescribe multiple medications at once. There is no clinical evidence, however, proving that this method is safe and effective. This study will assess whether adding a mood stabilizer, divalproex sodium, to stimulant treatment is more effective than stimulant treatment alone in reducing aggressive behavior among children with ADHD.
Participants in this double blind study will first receive open label stimulant treatment for ADHD and a comorbid disruptive behavior disorder. Participants whose aggressive behavior subsides with stimulant treatment alone will not proceed into the next phase of the study. Participants whose ADHD symptoms lessen from the treatment but whose aggressive behavior persists will be randomly assigned to receive either divalproex sodium or placebo in addition to their stimulant treatment for 8 weeks. Study visits will be held weekly for 11 to 16 weeks. At these visits, aggression levels and medication side effects will be assessed. Families will also meet with the researchers to discuss the child's progress, and attend behavioral counseling with a therapist. Participants who did not continue into the second phase of the study will be asked to return to the study site for a follow-up visit 8 weeks following the end of the first phase.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Diagnosis of ADHD
- Diagnosis of opposition defiant disorder or conduct disorder
- Score that exceeds the study threshhold on the standardized scale of aggressive behavior
Exclusion criteria
- Current psychosis
- Current major depression
- Current pervasive developmental disorder
- Current obsessive compulsive disorder
- Any other anxiety disorder as primary diagnosis
- Mental retardation
Treatment and study plan
Methylphenidate
DrugDextroamphetamine
DrugMixed Amphetamine Salts
DrugFamily Counseling
BehavioralBehavior Management Training with Parents
BehavioralPrimary outcomes
-
Aggression (Measured by the Overt Aggression Scale after 8 weeks of treatment)
-
Improvement of ADHD symptoms (Measured by the Clinical Global Improvement Scale and ADHD Rating Scale after 8 weeks of treatment)
Sponsors and collaborators
Lead sponsor
Stony Brook University
Other
Collaborators
- National Institute of Mental Health (NIMH)
Registry information
Official study title
Double-Blind, Placebo-Controlled Trial of Flexible Dose Divalproex Sodium Adjunctive to Stimulant Treatment for Aggressive Children With Attention-Deficit Hyperactivity Disorder
Important dates
- Study start
- 2004
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Sep 28, 2005
- Registry last updated
- Oct 31, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
School-Based Mental Health Services for Urban Children
NCT00612690
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Chicago, Illinois, United States
View Trial DetailsPhase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
NCT00626236
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Bradenton, Florida, United States
View Trial DetailsBrain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
NCT04170738
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
New York, United States
View Trial DetailsBrain Changes in Children and Adolescents With Behavioral Problems
NCT00104039
Antisocial Personality Disorder, Attention Deficit Disorder With Hyperactivity
Bethesda, Maryland, United States
View Trial Details